Ad
related to: robert blum cytokinetics
Search results
Insider Sell: Cytokinetics Inc's President & CEO Robert Blum Sells 12,500 Shares
GuruFocus.com via Yahoo Finance· 8 months agoOn September 13, 2023, Robert Blum, President & CEO of Cytokinetics Inc (NASDAQ:CYTK), sold 12,500...
Cytokinetics CEO: Why It's OK Not Being An Overnight Success
Investor's Business Daily· 2 years agoNobody will accuse Cytokinetics of being an "overnight success," Chief Executive Robert Blum says....
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
Investor's Business Daily· 4 months agoCytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double over a month as...
Shareholders Will Most Likely Find Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Cytokinetics to hold its Annual General Meeting on 10th of May Total pay for CEO Robert...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 2 weeks agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
Cytokinetics secures up to $575M in royalty deal, frustrating investors
BioPharma Dive via Yahoo Finance· 3 days agoThe biotech’s decision to give Royalty Pharma a greater share of future drug sales suggests a lower...
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Earnings Call Transcript February 27, 2024...
Cytokinetics Has Clawed Back 105% Over Seven Days. Now It Could Score A Buyout.
Investor's Business Daily· 5 months agoNovartis is closing in on a takeover of Cytokinetics, the Wall Street Journal reported Monday. CYTK...
Q3 2023 Cytokinetics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Andrew M. Callos; Executive VP & Chief Commercial Officer; Cytokinetics, Incorporated Ching W. Jaw; Senior VP & CFO; Cytokinetics, Incorporated Diane Weiser; SVP of Corporate Communications ...
Cytokinetics Inc (CYTK) Reports Q4 and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoNet Loss: Q4 net loss of $136.9 million ($1.38 per share), full-year net loss of $526.2 million...
